Day: October 7, 2021

DENVER, Oct. 07, 2021 (GLOBE NEWSWIRE) — First Western Financial, Inc. (NASDAQ: MYFW), a financial services holding company headquartered in Denver, Colorado (“First Western”), announced today that it will release financial results for its third quarter ended September 30, 2021 after the markets close on Thursday, October 21, 2021. Management will hold a conference call at 10:00 a.m. Mountain Time/12:00 p.m. Eastern Time on Friday, October 22, 2021, to discuss First Western’s financial results. Analysts and investors may participate in the question-and-answer session. The conference call will be webcast live on the News & Events page of First Western’s investor relations website. Conference Call, Webcast and Replay Information: Date: Friday, October 22, 2021 Time: 10:00 a.m. MT / 12:00 p.m. ET Telephone Access: (877) 405-1628 Telephone...

Improving overall Avant! mobile and web user’s experience, and connecting it with health-related data resources! SAN DIEGO, Oct. 07, 2021 (GLOBE NEWSWIRE) — GBT Technologies Inc. (OTC PINK: GTCH) (“GBT”, or the “Company”), is enhancing its Avant! AI technology, while enabling a healthcare advisory system. The company is in the process of an enhancement phase to improve Avant! back-end architecture, supporting better imaging and user interface. Advanced image recognition techniques are planned for implementation combined with efficient memory handling to enable faster performance. Avant! dialog interface is being enhanced, enabling robust Q/A possibilities combined with easier user interactions. Avant! will be trained with health-related information and connected with accredited data resources, enabling a generalized health...

VANCOUVER, British Columbia, Oct. 07, 2021 (GLOBE NEWSWIRE) — OOOOO Entertainment Commerce Limited (“OOOOO” or the “Company”) (OOOO:TSXV), a mobile commerce platform, is pleased to announce that the Company has joined forces with Teddy Sagi, technology and real estate billionaire and owner of LabTech – a property holding and management company which among other assets owns the vast majority of London’s iconic Camden Market. Globe Invest Limited, Teddy’s family office and investment vehicle, has agreed to provide consulting services to OOOOO, providing strategic input in its international studio expansion and M&A. This week will see the launch of a live broadcast studio in the centre of Camden Market for retailers, brands and entrepreneurs to broadcast their products and services during live video commerce via the OOOOO app. Teddy,...

TransUnion study finds that credit risk often changed based on when consumers exited hardship programs CHICAGO, Oct. 07, 2021 (GLOBE NEWSWIRE) — Despite financial challenges brought forth by the COVID-19 pandemic, a new study from TransUnion (NYSE: TRU) found that 18.7 million U.S. consumers that entered a financial hardship program experienced an increase to their VantageScore 4.0 credit risk scores in 2020. This accounted for 58% of the total hardship population (excluding student loans). Yet, the credit risk of those individuals in financial hardship programs often changed based on when they exited a hardship status. Financial hardship is defined by factors such as deferred payment and forbearance programs for credit products such as auto loans, credit cards, mortgages and personal loans. “COVID-19 has presented enormous financial...

CAMBRIDGE, Mass., Oct. 07, 2021 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that the Company will present preclinical data on its progress in the development of cell therapy medicines for the treatment of cancer at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting being held in Washington, D.C., and virtually, November 10-14, 2021. The Company will present a poster on its new method to drive high-level constitutive CD16 expression on the surface of iPSC-derived natural killer (iNK) cells through transgene knock-in (KI) at the GAPDH locus using an Editas-engineered AsCas12a. New preclinical data demonstrated that CD16 KI confers significantly increased cytotoxic activity in iNK cells against tumor cells compared with wild type iNK cells. Full details...

Technology Accurately Identifies Pathogens and Predicts Antimicrobial ResistanceIn less than 30 years, drug resistant bacteria are predicted to kill 3 times more people on an annual basis than COVID-19 did in 2020 MiQLab is a diagnostic tool used for detecting drug resistance at the point of care which will allow veterinarians to provide quality care for patients with suspected bacterial infections LexaGene’s MiQLab’s overall percent agreement in study:>99% for pathogen identification (106 samples) >96% for drug resistance markers in sequenced CDC bacterial strains (32 samples) >92% for drug resistance phenotype in canine urinary isolates with culture-based drug resistance profiles (74 samples)BEVERLY, Mass., Oct. 07, 2021 (GLOBE NEWSWIRE) — LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”),...

Collaboration enables Century to explore Outpace’s protein solutions for cell therapy to enhance functionality of iPSC platform Initial program to focus on hematological malignancies with option to expand to additional candidates PHILADELPHIA, Oct. 07, 2021 (GLOBE NEWSWIRE) — Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, and Outpace Bio, a cutting-edge biotechnology company building a platform to create next-generation smart cell therapies today announced a research collaboration in CAR engineering. The collaboration will bring together Century’s CAR and protein engineering expertise with Outpace’s protein design and synthetic biology capabilities to enhance CAR functionality by combining Outpace’s optimized CAR...

ST. CLOUD, Minn., Oct. 07, 2021 (GLOBE NEWSWIRE) — (TSX: NFI, OTC: NFYEF) NFI Group Inc. (“NFI” or the “Company”), a leading independent bus and coach manufacturer and a leader in electric mass mobility solutions, today announced that its subsidiary New Flyer of America Inc. (“New Flyer”) has received a new contract from Foothill Transit for 20 zero-emission, hydrogen fuel cell-electric Xcelsior CHARGE H2™ forty-foot heavy-duty transit buses. This order is supported by Federal Transit Administration (“FTA”) funds. Foothill Transit is based in West Covina, California, operating one of the largest fleets of electric buses in America and providing over 14 million trips annually in the San Gabriel and Pomona Valleys. Foothill Transit is a leader in deploying zero-emission bus (“ZEB”) technology in the United States – it...